Roche Medicaments

Roche - Pharmaceutical Business review

Roche - Pharma Journal

After Failed Tests: Roche Pulls the Plug on Bre...

Roche | Pharma Partnering Contact page

Roche | Pharma

Roche Pharma enters ophthalmology segment

Roche | Roche Pharma

Obesity drug from Roche shows promise in early ...

Roche Romania implements new distribution model...

Roche enters obesity drug market with Carmot deal

New Cancer Immunotherapy Fails in First Roche T...

Roche Pharmaceuticals – Element Data

Switzerland's Roche reports promising results f...

Roche Holdings: Hold If You Have It, But Do Not...

Roche Sales Rise on Cancer Drugs - WSJ

Qui sommes-nous ? | Roche

Roche Says Drug Meets Bladder Cancer Target - WSJ

Roche buys U.S. rights to Roivant bowel disease...

Roche Pharmaceuticals (division of Roche Group)...

Roche Announces $250M Deal to Acquire Good Ther...

Roche Pharmaceutical Company Name On Labels Sto...

Roche Revenue Lifted by Cancer and Immunology D...

Roche and Exelixis detail rare success for Cabo...

en

Roche’s MS Drug Reports Promising Results - WSJ

FDA Approves Roche Immunotherapy for Bladder Ca...

Roche begins new clinical trials of multiple sc...

Roche, Blueprint lung cancer drug wins FDA appr...

Pharmaceutical Technology

A history of Roche

Roche scraps Alzheimer’s drug trials after fail...

EMA CHMP recommends approval for Roche’s therap...

Pharma Careers for Doctors at Roche – Medic Foo...

Roche Fights Roche for $9 Billion Drug Business...

Roche | Our pharmaceuticals